ConductScience.org, home

Paper23917458

The effect of tranexamic acid on hemoglobin levels during total knee arthroplasty.

Pachauri A and 2 others. Am J Ther, 2014. Cited by 16 papers, by iCite.

Cite this record

ConductScience Library. The effect of tranexamic acid on hemoglobin levels during total knee arthroplasty. Papers, record 23917458. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23917458

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The effect of tranexamic acid on hemoglobin levels during total knee arthroplasty.
PubMed
Journal
Am J Ther
PubMed
Year
2014
PubMed
Publication types
Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
16
iCite
Relative citation ratio, by iCite
0.87
iCite
Revised in PubMed
2022-03-18
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Pachauri AAmit
2Acharya KKKiran K
3Tiwari AKAkhilesh Kumar

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antifibrinolytic AgentsMajor topic
Arthroplasty, Replacement, KneeMajor topic
HemoglobinsMajor topic
Tranexamic AcidMajor topic
Adult
Aged
Double-Blind Method
Female
Humans
Male
Middle Aged
Prospective Studies

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT04443920Tranexamic Acid for Total Knee ArthroscopyResults

Source ClinicalTrials.gov

Download CSV of trials

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.

PMIDTitleJournalYearIn PapersSource
41438392Combining topical and intravenous tranexamic acid in cardiac surgery: does it really matter? - a systematic review and meta-analysis.Int J Cardiol Heart Vasc2026https://conductscience.org/library/papers/41438392PubMed
38226724Pharmacological interventions for the prevention of bleeding in people undergoing elective hip or knee surgery: a systematic review and network meta-analysis.Cochrane Database Syst Rev2024https://conductscience.org/library/papers/38226724PubMed
36878889The Optimal Dose, Efficacy and Safety of Tranexamic Acid and Epsilon-Aminocaproic Acid to Reduce Bleeding in TKA: A Systematic Review and Bayesian Network Meta-analysis.Orthop Surg2023https://conductscience.org/library/papers/36878889PubMed
36575630Combination of Intravenous and Intra-Articular Application of Tranexamic Acid and Epsilon-Aminocaproic Acid in Primary Total Knee Arthroplasty: A Prospective Randomized Controlled Trial.Orthop Surg2023https://conductscience.org/library/papers/36575630PubMed
32000816A new improvement: subperiosteal cocktail application to effectively reduce pain and blood loss after total knee arthroplasty.J Orthop Surg Res2020https://conductscience.org/library/papers/32000816PubMed
31680743Reducing perioperative blood loss with antifibrinolytics and antifibrinolytic-like agents for patients undergoing total hip and total knee arthroplasty.J Orthop2019https://conductscience.org/library/papers/31680743PubMed
29977148EFFICACY OF TRANEXAMIC ACID IN REDUCING BLOOD LOSS IN TOTAL KNEE ARTHROPLASTY.Acta Ortop Bras2018https://conductscience.org/library/papers/29977148PubMed
29337665Safety of intravenous tranexamic acid in patients undergoing majororthopaedic surgery: a meta-analysis of randomised controlled trials.Blood Transfus2018https://conductscience.org/library/papers/29337665PubMed
27217813EFFECT OF TRANEXAMIC ACID ON BLEEDING CONTROL IN TOTAL KNEE ARTHROPLASTY.Acta Ortop Bras2016https://conductscience.org/library/papers/27217813PubMed
25430635Is tranexamic acid clinically effective and safe to prevent blood loss in total knee arthroplasty? A meta-analysis of 34 randomized controlled trials.Eur J Orthop Surg Traumatol2015https://conductscience.org/library/papers/25430635PubMed

Download CSV of cited by

Drugs1

The drugs whose trials, in the Pipelines release, list the paper.

DrugChEMBL IDThe trials list it asTrialsIn Drugs and targets
TRANEXAMIC ACIDCHEMBL877Results1https://conductscience.org/library/drugs/CHEMBL877

Source ChEMBL

Download CSV of drugs

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Genes
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/23917458

GET https://conductscience.org/api/papers/v1/23917458/authors